{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T23:44:01Z","timestamp":1777419841614,"version":"3.51.4"},"reference-count":114,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Pharmacother"],"published-print":{"date-parts":[[2006,2]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To provide an overview of the safety and tolerability of newer agents used to treat bipolar disorder (BPD) and provide clinicians with management strategies for drug-related toxicity and adverse effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data Sources:<\/jats:title>\n                    <jats:p>MEDLINE was searched through July 2005 for BPD treatment, adverse effects, tolerability, safety, emerging agents, atypical antipsychotics, new antiepileptic drugs (AEDs), risperidone, quetiapine, clozapine, ziprasidone, aripiprazole, lamotrigine, topiramate, gabapentin, oxcarbazepine, and olanzapine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study Selection and Data Extraction:<\/jats:title>\n                    <jats:p>Results from randomized controlled trials, open-label studies, and reviews are described.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data Synthesis:<\/jats:title>\n                    <jats:p>Emerging agents recently approved for BPD include atypical antipsychotics and new AEDs. Safety and tolerability are as Important as efficacy because poor adherence in BPD worsens outcome; metabolic and other comorbidities pose specific challenges; and manic patients often require combination therapy, which increases adverse effects. Most atypical antipsychotics cause fewer extrapyramidal symptoms than conventional antipsychotics, but may cause more weight gain and metabolic complications. The newer AEDs generally cause less weight gain than the older agents, and some even promote weight loss. Several newer AEDs used in BPD also offer the advantages of fewer drug interactions and less need for therapeutic drug monitoring compared with older AEDs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Pending the results of ongoing controlled studies, several emerging agents may be useful additions to the therapeutic arsenal for BPD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1345\/aph.1g112","type":"journal-article","created":{"date-parts":[[2006,1,10]],"date-time":"2006-01-10T20:48:39Z","timestamp":1136926119000},"page":"276-285","source":"Crossref","is-referenced-by-count":14,"title":["Emerging Treatments for Bipolar Disorder: Safety and Adverse Effect Profiles"],"prefix":"10.1177","volume":"40","author":[{"given":"Patricia A","family":"Marken","sequence":"first","affiliation":[{"name":"Division of Pharmacy Practice; Professor of Psychiatry, Schools of Pharmacy and Medicine, University of Missouri\u2014Kansas City, Kansas City, MO"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald W","family":"Pies","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Tufts University School of Medicine, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2006,2,1]]},"reference":[{"key":"bibr1-aph.1G112","volume-title":"Text revision","author":"Diagnostic and statistical manual of mental disorders.","year":"2000","edition":"4"},{"key":"bibr2-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.52.6.805"},{"issue":"4","key":"bibr3-aph.1G112","first-page":"1","volume":"159","author":"Hirschfeld RMA","year":"2002","journal-title":"Am J Psychiatry"},{"key":"bibr4-aph.1G112","author":"Keck PE","year":"2004","journal-title":"Postgrad Med Special Rep"},{"key":"bibr5-aph.1G112","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v63n0404"},{"key":"bibr6-aph.1G112","volume-title":"Physicians' desk reference","year":"2005","edition":"59"},{"key":"bibr7-aph.1G112","volume-title":"Handbook of essential psychopharmacology","author":"Pies RW","year":"2005","edition":"2"},{"key":"bibr8-aph.1G112","first-page":"487","volume-title":"The American Psychiatric Publishing textbook of psychopharmacology","author":"Lieberman JA","year":"2003","edition":"3"},{"key":"bibr9-aph.1G112","first-page":"443","volume-title":"The American Psychiatric Publishing textbook of psychopharmacology","author":"Marder SR","year":"2003","edition":"3"},{"key":"bibr10-aph.1G112","first-page":"457","volume-title":"The American Psychiatric Publishing textbook of psychopharmacology","author":"Schulz SC","year":"2003","edition":"3"},{"key":"bibr11-aph.1G112","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v65n0219"},{"key":"bibr12-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.1.112"},{"key":"bibr13-aph.1G112","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v64n1205"},{"key":"bibr14-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852900008166"},{"key":"bibr15-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.2.290"},{"key":"bibr16-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.8.1334"},{"key":"bibr17-aph.1G112","volume-title":"Package insert. Geodon (ziprasidone HCl) capsules, Geodon (ziprasidone mesylate) for injection","year":"2005"},{"key":"bibr18-aph.1G112","volume-title":"FDA background on Zeldox\u00e4 (ziprasidone hydrochloride capsules)","author":"Laughren T","year":"2000"},{"key":"bibr19-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.6.1062-a"},{"key":"bibr20-aph.1G112","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v65n1116"},{"key":"bibr21-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(02)00335-X"},{"key":"bibr22-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145703003560"},{"key":"bibr23-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1002\/1099-1077(200010)15:7<499::AID-HUP194>3.0.CO;2-3"},{"key":"bibr24-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.6.1018"},{"key":"bibr25-aph.1G112","first-page":"231","volume":"28","author":"Reinares M","year":"2000","journal-title":"Adas Esp Psiquiatr"},{"key":"bibr26-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1023\/A:1020464017021"},{"key":"bibr27-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.156.5.702"},{"key":"bibr28-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.57.9.841"},{"key":"bibr29-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-2406.2003.00061.x"},{"key":"bibr30-aph.1G112","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v62n0410"},{"key":"bibr31-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.184.4.337"},{"key":"bibr32-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.156.11.1686"},{"key":"bibr33-aph.1G112","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v64n0506"},{"key":"bibr34-aph.1G112","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v65n1214"},{"key":"bibr35-aph.1G112","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v60n1109"},{"key":"bibr36-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.59.11.1021"},{"key":"bibr37-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-003-1529-4"},{"key":"bibr38-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000085404.08426.3a"},{"key":"bibr39-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.12.2241"},{"key":"bibr40-aph.1G112","first-page":"495","volume-title":"The American Psychiatric Publishing textbook of psychopharmacology","author":"Goff DC","year":"2003","edition":"3"},{"key":"bibr41-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.7.1146"},{"key":"bibr42-aph.1G112","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v62n1011"},{"key":"bibr43-aph.1G112","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v61n0907"},{"key":"bibr44-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1592\/phco.23.8.1037.32876"},{"key":"bibr45-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1592\/phco.23.6.735.32178"},{"key":"bibr46-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.9.1618"},{"key":"bibr47-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1002\/hup.577"},{"key":"bibr48-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-200405000-00010"},{"issue":"6","key":"bibr49-aph.1G112","first-page":"30","volume":"65","author":"Findling RL","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"bibr50-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(02)00075-7"},{"key":"bibr51-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(00)89080-3"},{"key":"bibr52-aph.1G112","first-page":"473","volume-title":"The American Psychiatric Publishing textbook of psychopharmacology","author":"Lieberman JA","year":"2003","edition":"3"},{"key":"bibr53-aph.1G112","volume-title":"Package insert. Seroquel (quetiapine fumate)","year":"2005"},{"key":"bibr54-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.4.741"},{"key":"bibr55-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2.6.1033"},{"key":"bibr56-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1592\/phco.21.7.717.34575"},{"key":"bibr57-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2.10.1655"},{"key":"bibr58-aph.1G112","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v65n0122a"},{"key":"bibr59-aph.1G112","first-page":"66","volume":"35","author":"Kelly DL","year":"2001","journal-title":"Psychopharmacol Bull"},{"key":"bibr60-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.3.12.1773"},{"key":"bibr61-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.9.1651"},{"key":"bibr62-aph.1G112","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v66n0118c"},{"key":"bibr63-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.156.8.1164"},{"key":"bibr64-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.153.6.759"},{"key":"bibr65-aph.1G112","first-page":"411","volume":"56","author":"Zarate CA","year":"1995","journal-title":"J Clin Psychiatry"},{"key":"bibr66-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1080\/714858480"},{"key":"bibr67-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.44.12.2247"},{"key":"bibr68-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.schbul.a033333"},{"key":"bibr69-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.169.4.483"},{"key":"bibr70-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-200103000-00001"},{"key":"bibr71-aph.1G112","doi-asserted-by":"publisher","DOI":"10.3109\/10401230309085668"},{"key":"bibr72-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.60.4.392"},{"key":"bibr73-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000123695.22623.32"},{"key":"bibr74-aph.1G112","volume-title":"Principles and practice of psychopharmacotherapy","author":"Janicak PG","year":"2001","edition":"3"},{"key":"bibr75-aph.1G112","first-page":"303","volume-title":"The American Psychiatric Press textbook of psychopharmacology","author":"Lenox RH","year":"1995","edition":"1"},{"key":"bibr76-aph.1G112","doi-asserted-by":"crossref","unstructured":"Maxmen JS. Antidepressants. Psychotropic drugs: fast facts. 1st ed. New York: WW Norton & Company, 1991: 57\u201397.","DOI":"10.1097\/00004850-199200710-00010"},{"key":"bibr77-aph.1G112","first-page":"615","volume-title":"The American Psychiatric Publishing textbook of psychopharmacology","author":"Shelton MD","year":"2003","edition":"3"},{"key":"bibr78-aph.1G112","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v65n0210"},{"key":"bibr79-aph.1G112","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200427030-00002"},{"issue":"8","key":"bibr80-aph.1G112","first-page":"22","volume":"64","author":"Aronne LJ","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"bibr81-aph.1G112","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v65n1107"},{"key":"bibr82-aph.1G112","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v63n1110"},{"key":"bibr83-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2000.19107"},{"key":"bibr84-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852900028704"},{"key":"bibr85-aph.1G112","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v63n1109"},{"key":"bibr86-aph.1G112","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v66n0516"},{"key":"bibr87-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.55.4.588"},{"key":"bibr88-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2000.100544"},{"key":"bibr89-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(02)00338-5"},{"key":"bibr90-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-5618.2002.02228.x"},{"key":"bibr91-aph.1G112","first-page":"479","volume-title":"Antiepileptic drugs","author":"Kramer G","year":"2002","edition":"5"},{"key":"bibr92-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1358\/dot.2001.37.5.627955"},{"key":"bibr93-aph.1G112","volume-title":"Package insert. Trileptal (oxycarbazepine)","year":"2005"},{"key":"bibr94-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200208000-00017"},{"key":"bibr95-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1080\/15622970310029915"},{"key":"bibr96-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2004.10.013"},{"key":"bibr97-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-5618.2001.30501.x"},{"key":"bibr98-aph.1G112","doi-asserted-by":"publisher","DOI":"10.3109\/10401230309085691"},{"key":"bibr99-aph.1G112","volume-title":"Prescribing information. Topamax (topiramate)","year":"2004"},{"key":"bibr100-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-5618.2000.20305.x"},{"key":"bibr101-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200012000-00004"},{"key":"bibr102-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3956(98)00010-7"},{"key":"bibr103-aph.1G112","first-page":"354","volume-title":"Antiepileptic drugs","author":"Ramsay RE","year":"2002","edition":"5"},{"key":"bibr104-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(98)00192-X"},{"key":"bibr105-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-199708000-00006"},{"key":"bibr106-aph.1G112","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v64n0707"},{"key":"bibr107-aph.1G112","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v66n0314"},{"key":"bibr108-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-1211(01)00296-0"},{"key":"bibr109-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1016\/0920-1211(93)90021-X"},{"key":"bibr110-aph.1G112","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v61n0104"},{"key":"bibr111-aph.1G112","doi-asserted-by":"publisher","DOI":"10.3109\/10401230209147461"},{"key":"bibr112-aph.1G112","doi-asserted-by":"publisher","DOI":"10.3109\/10401230309085690"},{"key":"bibr113-aph.1G112","doi-asserted-by":"publisher","DOI":"10.1201\/b15278"},{"issue":"21","key":"bibr114-aph.1G112","first-page":"16","volume":"60","author":"Sachs GS","year":"1999","journal-title":"J Clin Psychiatry"}],"container-title":["Annals of Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1345\/aph.1G112","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1345\/aph.1G112","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:11:54Z","timestamp":1777374714000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1345\/aph.1G112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":114,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["10.1345\/aph.1G112"],"URL":"https:\/\/doi.org\/10.1345\/aph.1g112","relation":{},"ISSN":["1060-0280","1542-6270"],"issn-type":[{"value":"1060-0280","type":"print"},{"value":"1542-6270","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}